GL1X · GenesisL1 explorer

MolNFT v1 · #135940 · protein + RNA

Human LIN28A in complex with let-7F-1 microrna pre-element

5UDZ · Protein lin-28 homolog a: “Human LIN28A in complex with let-7F-1 microrna pre-element”. X-ray diffraction, 1 ligand (ZN), 7 pockets (best druggability 0.58). MolNFT v1 #135940 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5UDZ
Type
protein + RNA
Length
325 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein lin-28 homolog a; Let-7F-1 pre-element
UniProt
Q9H9Z2
Ligands
ZN
Pockets
7 · best druggability 0.58

Structure

x-ray diffraction · 3 distinct chains · 12% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtein lin-28 homolog aprotein13912% helix, 36% strandQ9H9Z2
VLet-7F-1 pre-elementrna24——
WLet-7F-1 pre-elementrna23——

Ligands and binding sites

  • ZN · Zinc ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14770.580.7453empty
2790.490.8418empty
3520.420.8314empty
4540.420.8313empty
5540.400.8115empty

Interfaces

4 interfaces between chains.

  • A–V · 1307 Ų buried · 32 hydrogen bonds · protein-nucleic
  • B–W · 1220 Ų buried · 19 hydrogen bonds · protein-nucleic
  • B–V · 828 Ų buried · 25 hydrogen bonds · protein-nucleic
  • A–W · 815 Ų buried · 23 hydrogen bonds · protein-nucleic

Compared structures

  • 5UDZ · Human LIN28A in complex with let-7f-1 microRNA pre-element · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H9Z2 · AlphaFold monomer V2.0 prediction for protein lin-28 homolog a (Q9H9Z2) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.